Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PDUFA
Biotech
FDA delays decision on Moderna's RSV shot until the end of May
Investors were largely undeterred by the FDA delaying a decision on Moderna's RSV candidate until the end of May.
Max Bayer
May 10, 2024 10:30am
Applied Tx’s pediatric rare disease prosect hits another snag
Mar 29, 2024 10:21am
Karuna's schizophrenia drug set for FDA decision in Q3 2024
Nov 29, 2023 10:00am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am
GSK's RSV shot rises over peers with expected May FDA decision
Nov 2, 2022 10:06am
Good news or bad news? FDA delays decision for Amylyx's ALS drug
Jun 3, 2022 10:25am
